home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Understanding How Cancer Drug Works Could Improve Therapy

  August, 2 2001 0:19
your information resource in human molecular genetics
Ecteinascidin 743, a compound derived from the Caribbean sea squirt Ecteinascidia turbinata, is currently being tested as an anticancer treatment in clinical trials against a range of tumors. Understanding how this compound works might help guide the choice of which cancers it is used to treat.

When mutations in cellular DNA occur they are often fixed by DNA repair mechanisms. One such repair kit is called nucleotide excision repair (NER), which removes damaged sections of DNA and replaces them with the correct ones. UV-light-induced skin carcinogenesis and neurodegeneration are the result of a defective NER system in humans.

By experimenting with human cancer cell lines that are resistant to the effects of Ecteinascidin 743, Yves Pommier and colleagues at the US National Cancer Institute have discovered that the compound alters the NER process, and rather than repairing the damaged DNA, Ecteinascidin 743 causes the NER machinery to create lethal breaks in the DNA, thus killing cells (Nature Medicine, Vol. 7, No. 8, 01 Aug 01).

Dr. Yves Pommier
Building 37
Room 4E28
National Cancer Institute
National Institutes of Health
Bethesda, MD, USA
Tel: (+1) 301 496 5944
Fax: (+1) 301 402-0752
Email: pommier@nih.gov

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.